These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25575823)

  • 1. DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance.
    Huber RM; Lucas JM; Gomez-Sarosi LA; Coleman I; Zhao S; Coleman R; Nelson PS
    Oncotarget; 2015 Feb; 6(4):2134-47. PubMed ID: 25575823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA Damage Induces a Secretory Program in the Quiescent TME that Fosters Adverse Cancer Phenotypes.
    Gomez-Sarosi L; Sun Y; Coleman I; Bianchi-Frias D; Nelson PS
    Mol Cancer Res; 2017 Jul; 15(7):842-851. PubMed ID: 28356331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors.
    Morandi A; Martin LA; Gao Q; Pancholi S; Mackay A; Robertson D; Zvelebil M; Dowsett M; Plaza-Menacho I; Isacke CM
    Cancer Res; 2013 Jun; 73(12):3783-95. PubMed ID: 23650283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of brefelamide on proliferation of 1321N1 human astrocytoma cells induced by glial cell line-derived neurotrophic factor.
    Honma S; Kouno K; Takasaka S; Mitazaki S; Abe S; Kikuchi H; Oshima Y; Yoshida M
    Pharmazie; 2018 Jan; 73(1):22-28. PubMed ID: 29441947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GFRA1: A Novel Molecular Target for the Prevention of Osteosarcoma Chemoresistance.
    Kim M; Kim DJ
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29617307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GDNF/GFRA1 signaling contributes to chemo- and radioresistance in glioblastoma.
    Avenel ICN; Ewald JD; Ariey-Bonnet J; Kristensen IH; Petterson SA; Thesbjerg MN; Burton M; Thomassen M; Wennerberg K; Michaelsen SR; Kristensen BW
    Sci Rep; 2024 Jul; 14(1):17639. PubMed ID: 39085346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glial cell line-derived neurotrophic factor influences proliferation of osteoblastic cells.
    Gale Z; Cooper PR; Scheven BA
    Cytokine; 2012 Feb; 57(2):276-81. PubMed ID: 22142702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for glial cell derived neurotrophic factor induced expression by inflammatory cytokines and RET/GFR alpha 1 receptor up-regulation in breast cancer.
    Esseghir S; Todd SK; Hunt T; Poulsom R; Plaza-Menacho I; Reis-Filho JS; Isacke CM
    Cancer Res; 2007 Dec; 67(24):11732-41. PubMed ID: 18089803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling.
    Sawai H; Okada Y; Kazanjian K; Kim J; Hasan S; Hines OJ; Reber HA; Hoon DS; Eibl G
    Cancer Res; 2005 Dec; 65(24):11536-44. PubMed ID: 16357163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.
    Li X; Wu JB; Chung LW; Huang WC
    Oncotarget; 2015 Dec; 6(38):41018-32. PubMed ID: 26512780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of glial cell line-derived neurotrophic factor and neurturin in RET/GFRalpha1-expressing cells.
    Lee RH; Wong WL; Chan CH; Chan SY
    J Neurosci Res; 2006 Jan; 83(1):80-90. PubMed ID: 16294336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KLK5 gene expression is severely upregulated in androgen-independent prostate cancer cells after treatment with the chemotherapeutic agents docetaxel and mitoxantrone.
    Mavridis K; Talieri M; Scorilas A
    Biol Chem; 2010 Apr; 391(4):467-74. PubMed ID: 20128692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paracrine regulation of glioma cells invasion by astrocytes is mediated by glial-derived neurotrophic factor.
    Shabtay-Orbach A; Amit M; Binenbaum Y; Na'ara S; Gil Z
    Int J Cancer; 2015 Sep; 137(5):1012-20. PubMed ID: 25487790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gdnf-Gfra1 pathway is expressed in a spermatogenetic-dependent manner and is regulated by Fsh in a fish testis.
    Bellaïche J; Goupil AS; Sambroni E; Lareyre JJ; Le Gac F
    Biol Reprod; 2014 Oct; 91(4):94. PubMed ID: 25165121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of docetaxel resistance genes in castration-resistant prostate cancer.
    Marín-Aguilera M; Codony-Servat J; Kalko SG; Fernández PL; Bermudo R; Buxo E; Ribal MJ; Gascón P; Mellado B
    Mol Cancer Ther; 2012 Feb; 11(2):329-39. PubMed ID: 22027694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity.
    Qian DZ; Rademacher BL; Pittsenbarger J; Huang CY; Myrthue A; Higano CS; Garzotto M; Nelson PS; Beer TM
    Prostate; 2010 Mar; 70(4):433-42. PubMed ID: 19866475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibronectin confers survival against chemotherapeutic agents but not against radiotherapy in DU145 prostate cancer cells: involvement of the insulin like growth factor-1 receptor.
    Thomas F; Holly JM; Persad R; Bahl A; Perks CM
    Prostate; 2010 Jun; 70(8):856-65. PubMed ID: 20127733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathways: involving microenvironment damage responses in cancer therapy resistance.
    Sun Y; Nelson PS
    Clin Cancer Res; 2012 Aug; 18(15):4019-25. PubMed ID: 22619305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candidate markers that associate with chemotherapy resistance in breast cancer through the study on Taxotere-induced damage to tumor microenvironment and gene expression profiling of carcinoma-associated fibroblasts (CAFs).
    Rong G; Kang H; Wang Y; Hai T; Sun H
    PLoS One; 2013; 8(8):e70960. PubMed ID: 23951052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
    Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
    Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.